Search

Search Constraints

You searched for: Author/Creator Hetzer, Joel

Search Results

1. Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher‐risk myelodysplastic syndromes. (28th January 2014)

2. CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia. (September 2018)